P1441: Association between Caffeine Consumption and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
Author insight from Huafeng Shen, MD, Nassau University Medical Center, East Meadow, NY
What’s new here and important for clinicians?
This is the first meta-analysis regarding the association of caffeine consumption and nonalcoholic fatty liver disease.
What do patients need to know?
Regular coffee caffeine consumption may significantly reduce hepatic fibrosis in patients with NAFLD.
Author Contact: Huafeng Shen, MD
Media Interview Requests:
To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email firstname.lastname@example.org or by phone at 301-263-9000.